Peder M Andersen MD appointed as new CEO.

Biosergen has as of 1. September 2017 appointed Peder M Andersen MD as new CEO after Anders Kronstroem left to a new position. Dr Andersen has 30 years experience in the pharmaceutical industry and he comes from a recent position as CEO/COO at Forward Pharma A/S, Copenhagen.